|Bid||288.00 x 100|
|Ask||288.40 x 100|
|Day's Range||280.24 - 291.91|
|52 Week Range||244.28 - 333.65|
|PE Ratio (TTM)||17.72|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Earnings season kicked off on a positive note for biotech stocks with big players like Amgen (AMGN) and Biogen reporting better than expected results.
Biogen Inc. shares surged as much as 2% in premarket trade Wednesday after the company was upgraded to buy at Goldman Sachs and its price target was raised by nearly 20% to $338. Biogen shares closed at ...
While announcing record-breaking quarterly revenues and raising its forecast for full-year revenue, Biogen said Tuesday that it plans to “streamline its operations” in order to prioritize spending on developing ...